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Grubb BR, Livraghi-Butrico A, Rogers TD, Yin W, Button B,
Ostrowski LE. Reduced mucociliary clearance in old mice is asso-
ciated with a decrease in Muc5b mucin. Am J Physiol Lung Cell Mol
Physiol 310: L860–L867, 2016. First published March 11, 2016;
doi:10.1152/ajplung.00015.2016.—Respiratory infections are a major
cause of morbidity and mortality in the elderly. Previous reports have
suggested that mucociliary clearance (MCC) is impaired in older
individuals, but the cause is unclear. To unravel the mechanisms
responsible for the age-associated decline in MCC, we investigated
the MCC system in young (3 mo) and old (2 yr) C57BL/6 mice. We
found that old mice had significantly reduced MCC function in both
the upper and lower airways compared with young mice. Measure-
ment of bioelectric properties of isolated tracheal and bronchial tissue
revealed a significant decrease in Cl secretion, suggesting that the
older mice may have a reduced ability to maintain a sufficiently
hydrated airway surface for efficient MCC. Ciliary beat frequency was
also observed to be reduced in the older animals; however, this
reduction was small relative to the reduction in MCC. Interestingly,
the level of the major secreted mucin, Muc5b, was found to be
reduced in both bronchioalveolar lavage and isolated tracheal tissue.
Our previous studies of Muc5b/ mice have demonstrated that
Muc5b is essential for normal MCC in the mouse. Furthermore,
examination of Muc5b/ and wild-type animals revealed that
heterozygous animals, which secrete 50% of the wild-type level of
Muc5b, also demonstrate a markedly reduced level of MCC, confirm-
ing the importance of Muc5b levels to MCC. These results demon-
strate that aged mice exhibit a decrease in MCC and suggest that a
reduced level of secretion of both Cl and Muc5b may be responsible.
aging; mucociliary clearance
MUCOCILIARY CLEARANCE (MCC) is the first line of defense in
preventing viral and bacterial infections in both the upper and
lower airways (23, 49). Efficient MCC, whereby debris and
pathogens trapped in mucus are cleared from the airways by
ciliary beating, depends on the proper functioning of three
major systems: 1) the synthesis and secretion of mucin and
other mucus proteins, 2) the proper hydration of the airway
surface, and 3) the coordinated activity of the cilia. A pertur-
bation in any of these components can result in impaired MCC.
For example, patients with primary ciliary dyskinesia have
mutations in genes necessary for the proper formation or
function of cilia and in many cases have a complete absence of
MCC (6, 24, 31). These patients suffer from recurrent/chronic
rhinosinusitis, otitis media, and pulmonary infections and de-
velop bronchiectasis in an age-dependent fashion, clearly dem-
onstrating the importance of MCC to host defense (24). In
cystic fibrosis, mutations in the CFTR gene cause a defect in
Cl and hence water secretion that results in a dehydration of
mucus and impaired MCC that leads to chronic pulmonary
infections, bronchiectasis, and eventually lung failure (9, 17).
Similar mechanisms likely play a role in the pathogenesis of
chronic bronchitis and chronic obstructive pulmonary disease
(2). These and other diseases clearly demonstrate the impor-
tance of MCC to lung host defense and the prevention of
pulmonary infections.
It is well known that the elderly human population exhibits
an age-related increase in the incidence of pulmonary infec-
tions, resulting in substantial morbidity and mortality (8, 14,
27). In one study, the hospitalization rate for pneumonia
increased 12-fold in individuals over the age of 75 compared
with the general population (12). Although there are a number
of possible etiologies for these age-related pulmonary diseases,
including immunosenescence, a loss of muscle tone in respi-
ratory accessory muscles, and an increased incidence of aspi-
ration (for reviews, see Refs. 14, 28), a decrease in MCC has
also been suggested as a contributing factor. Although there is
good evidence in humans that MCC declines with age (19, 33,
41), no mechanisms for this age-related decline in MCC have
been suggested. With the exception of one study on aging
beagles (50), no studies could be located on the effect of aging
on MCC in species other than humans. The paucity of data on
the effect of aging on MCC reflects in part the lack of a
well-characterized model system.
The purpose of our studies was to first characterize MCC in
both young and old mice to determine whether the mouse is a
suitable model to study the age-dependent decline in MCC. We
therefore measured MCC in both the upper and lower airways
of young and old mice and found a significant decrease in
MCC in the older animals. To begin to investigate the mech-
anism responsible for this decrease, we investigated each of the
major components involved in MCC (cilia, mucus, and ion
transport). Our results suggest that a lower level of mucin and
Cl secretion may play a key role in the age-dependent
reduction of MCC. Furthermore, our results suggest that strat-
egies to improve/maintain adequate MCC in the elderly may
reduce the incidence and severity of pulmonary infections in
this susceptible population.
MATERIAL AND METHODS
All mouse studies were approved by the University of North
Carolina (UNC) Institutional Animal Care and Use Committee. Male
C57BL/6 mice, 3 mo or 2 yr of age, obtained from the NIA aged
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rodent colonies were used in this investigation. A 3-mo-old mouse is
roughly equivalent to a 20- to 30-yr-old human (mature adult), and a
2-yr-old mouse is roughly equivalent to a 55- to 70-yr-old human
(www.jax.org). Mean body mass of 3-mo-old males was 26.3  0.5
g and of 2-yr-old males was 33.8  0.6 g (means  SE). After arrival
at UNC the mice were allowed to acclimate for at least 1 wk prior to
being studied. All animals were allowed food and water ad libitum
until the time of study.
Mucociliary clearance measurement in the upper airways. To
determine the rate of MCC in the anterior nasopharynx (ANP) of the
nasal cavity, the mice were anesthetized (2.5% isoflurane) and then
euthanized by severing the abdominal aorta. The lower jaw was
removed and a small incision made in the lateral wall of the ANP
(hard palate) at the level of the nasopalatine duct. A 35-gauge silica
cannula (WPI, Sarasota, FL) was dipped to a depth of 5 mm into an
aliquot of dry green fluorescent 7-m beads (Thermo Scientific,
Fremont, CA). The dry beads adhered to the outside of the cannula by
static electricity. The cannula with the adherent beads was then
introduced into the ANP via the incision. Enough beads were depos-
ited on the surface of the nasal tissue by contact with the cannula to
allow easy quantification of MCC by tracking the beads in the ANP.
The preparation was placed under a dissecting microscope with a
fluorescent lamp outfitted with a video camera (MTI, Michigan City,
IN). The camera was interfaced to a DVD recorder for image acqui-
sition. The beads could be clearly seen moving caudally inside the
nasal cavity toward the posterior nasopharynx. The rate of MCC was
measured downstream of the site of bead introduction. Before the
MCC was recorded, a slide micrometer was placed on the stage of the
dissecting scope to calibrate distance measurements. Once the video
was recorded, MCC was determined by playing back the video and
determining the time it took fluorescent particles to traverse a cali-
brated distance on the screen monitor (corresponding to an in vivo
distance of 0.5–1 mm). Usually 10–30 particles were tracked per
mouse over a 10-min period. There was no systematic change in the
rate of MCC over the 10-min time period in the majority of the mice.
The rate of MCC was calculated as millimeters per minute.
Mucociliary clearance measurement in the lower airways. To
measure MCC in the lower airways, the mice were anesthetized and
euthanized as described above. The muscle and connective tissue
covering the uppermost trachea (1 cm) was retracted and a very
small incision (0.5 mm) was made through the ventral wall of the
trachea. Then, via a fine-bore 34-gauge silica cannula (WPI) inter-
faced to a 0.5-l SGE analytical syringe (Trajan Scientific Americas,
Austin, TX), 200 nl of PBS containing fluorescent microspheres (3
m, Molecular Probes FluoSpheres, Nile Red, Invitrogen, Carlsbad,
CA) were deposited in the main stem bronchi just below the tracheal
bifurcation. After deposition, the cannula was removed and the wound
closed with a wound clip. After 15 min the lungs and trachea were
removed, weighed, and placed in 3 M KOH for 24 h to dissolve the
tissue; 10 l of the dissolved lung preparation was placed on a
hemocytometer under a 2 objective (Nikon Eclipse scope with
fluorescence) and photographed for counting with Image J software.
Three aliquots from each mouse were counted and averaged. The
percentage of beads cleared in the 15-min period was calculated by
determining the difference between the number of beads injected and
the number of beads recovered. To determine the number of beads
injected, six aliquots of the bead suspension (200 nl) were counted in
a similar manner prior to injection. The coefficient of variation on the
six replicates was less than 5%, demonstrating that the number of
beads deposited in the trachea was highly reproducible. Instilling
small beads into the lower airways and quantifying the percentage of
beads remaining in the airways after a defined time interval as a
measure of MCC has previously been used in both rats (10) and mice
(32, 35). In the modified procedure used here, a small opening is made
in the trachea so that very small volumes (200 nl) of beads can be
introduced; thus the airway surface liquid volume is minimally dis-
turbed.
Measurement of ciliary beat frequency. Tracheas were isolated
from 3-mo-old and 2-yr-old male mice immediately after euthanasia
and placed in a petri dish containing sterile F12 media. Tracheal rings
(0.5–1.0 mm) were cut from the trachea with a razor blade and five
to six rings were transferred to a 60-mm petri dish containing 1.5 ml
F12 media. The dish was placed on the heated stage (25°C; Zeiss
TempControl 37-2) of a Nikon Eclipse TE2000 inverted microscope
with phase optics (20). Videos (60 fps; 2 s) of active areas of ciliary
activity (usually 1–3/tracheal ring) were captured with a Redlake
ES-310T camera driven by SAVA software (Ammons Engineering,
Clio, MI). The SAVA software was also used for ciliary beat fre-
quency (CBF) determination with the whole field analysis option. The
measurements from all tracheal rings were combined to provide an
average CBF for each animal, and old and young animals were studied
alternately.
Lung histology. Lung tissue was fixed in 10% neutral buffered
formalin and embedded in paraffin. Sections (4–6 m) were prepared
and stained with hematoxylin and eosin to examine lung morphology
and Alcian blue/periodic acid-Schiff to visualize mucus. For quanti-
fication of lymphoid hyperplasia, one section from each lobe, sec-
tioned to maximize visualization of the primary bronchi, was scored
semiquantitatively from 0 to 3, as previously described (25). Sections
with no areas of hyperplasia  0, one area  1, two areas  2, and
those with 3 or more  3. Two different groups of animals were
examined.
Tracheal and bronchial bioelectrics. Mice were euthanized as
described above and tracheas and bronchi were immediately excised
and mounted in Ussing chambers. Ussing chamber measurements of
the bioelectric properties of tracheal and bronchial epithelia were
made under short-circuit current (Isc) conditions, as previously de-
scribed (15, 16). Tissues were bathed bilaterally in Krebs-Ringer
bicarbonate solution. The experimental protocol was; amiloride (104
M) added to the apical surface to block electrogenic Na absorption,
forskolin (105 M) and then UTP (104 M) were added to the apical
surface to induce anion secretion via an increase in cellular cAMP and
Ca2, respectively, and finally bumetanide (104) was added to the
basolateral side to block Cl secretion. All chemicals were purchased
from Sigma, with the exception of UTP (Amersham Pharmacia
Biotech).
Quantification of mucin. Mice (n  10/age group) were weighed,
anesthetized with 2,2,2-tribromoethanol, and exsanguinated by resec-
tion of the inferior vena cava. The thoracic cavity was opened, the
thymus removed, and the trachea exposed. An 18-gauge blunt needle
was inserted just above the airway bifurcation and secured in place
with suture. The upper four tracheal rings were collected as “submu-
cosal glands” sample, and the remainder of the trachea was collected
as “trachea” sample. Both were weighed, opened longitudinally by
microdissection, submerged in 120 l of 6 M urea in PBS, and
incubated at 4°C for 24 h, with occasional mixing through a 200-l
pipette tip. Bronchoalveolar lavage (BAL) was performed by instilling
and retrieving 1 ml of room temperature PBS containing protease
inhibitors (Roche, cOmplete tablets mini, Indianapolis, IN) through
the 18-gauge blunt needle. This procedure was repeated three times
and the three fractions were pooled to generate a 3-ml BAL sample,
to which powdered urea was added to reach 6 M concentration (0.4
g/ml). All samples were reduced with 10 mM dithiothreitol and
alkylated with iodoacetamide to analyze mucin levels by agarose
Western blot, as described in Ref. 25. Nitrocellulose membranes were
probed with rabbit polyclonal antibodies against Muc5b [UNC223,
1:2,000 dilution in Odyssey blocking buffer (LI-COR Biotechnology,
Lincoln, NE) (51)] and Muc5ac [UNC294, 1:1,000 dilution in Odys-
sey blocking buffer 0.1% Tween-20 (11)].
Statistics. All data are shown as means  SE. A Student’s t-test
was used to compare means between two groups. When more than
two groups were compared, an ANOVA was used for the comparison.
P  0.05 was considered statistically significant.
RESULTS
Mucociliary clearance is reduced in both the upper and
lower airways of aged mice. To determine whether old mice
display a reduced rate of MCC and would therefore be suitable
as a model to investigate the mechanisms responsible for
reduced MCC in older humans, we first compared the rate of
MCC in a cohort of adult (young; 3 mo old) and old (old; 2 yr
old) mice. The rate of MCC in the nasal cavity (ANP) of the
young animals averaged 11.2  1.3 mm/min (Fig. 1A), which
is in good agreement with our previous studies using this
technique (32). The rate of clearance in the old mice was
reduced to 5.6  0.8 min/min, which was significantly de-
creased compared with the young animals (55%; P  0.001;
Fig. 1A). In the lower airways, the percentage of beads cleared
was again significantly decreased in the old mice (10.7 
5.4%) compared with the younger animals (34.4  6.3%; P 
0.01; Fig. 1B). These results demonstrate that MCC decreases
with age in mice, similar to observations in humans, and
suggest that the mouse may be a good model system to study
the mechanisms responsible for the age-dependent decline in
MCC.
Ciliary beat frequency is reduced in old mice. To determine
whether a reduction in CBF could be responsible for the
reduced MCC observed in the older animals, CBF was mea-
sured in the tracheas of old and young mice. Tracheal rings
were prepared from both groups of animals and CBF was
measured in several rings from each animal. Average CBF in
the old animals was 10.4  0.2 Hz (average  SE; n  22)
compared with 11.2  0.3 Hz (n  23) in the younger animals.
This result indicates that CBF is significantly reduced in older
mice (P 	 0.02). However, the magnitude of the reduction
(	10%) is small relative to the reduction in MCC (50–70%).
Measurement of airway bioelectric properties reveals a
decrease in chloride secretion in old mice. The absorption and
secretion of ions (principally Na and Cl) in airway epithelia
is accompanied by osmotically driven water flow that is im-
portant for maintaining proper hydration (i.e., mucus concen-
tration) of the airway surface. We measured bioelectric prop-
erties of both the trachea and bronchi from young and old mice
to determine whether age affects Na absorption or Cl
secretion of airway epithelia. The basal Isc as well as the
postamiloride residual Isc were significantly decreased in
the tracheal epithelium of the old mice compared with that of
the younger animals (Fig. 2A). The residual Isc was also
significantly decreased in the bronchi from the old mice (Fig.
2B). Previous studies indicate that the basal Isc is a combination
of ENaC-mediated Na absorption and Cl secretion (34). The
response to amiloride was not age dependent in either the
trachea or bronchi, suggesting that the decrease in basal Isc, and
particularly the reduced residual Isc, in the old mice was a
result of a decrease in Cl secretion. In both the trachea and
bronchi from the old mice, there was a significant decrease in
the response to UTP, a Ca-activated Cl secretory response
(Fig. 2, A and B). As we have previously reported, the trachea
of neither group responded to the Cl channel blocker bumet-
anide (Ref. 16; data not shown because the responses were
zero). However, both groups of bronchi responded to bumet-
anide, but again the old mice had a significantly attenuated
response, further suggesting a reduced rate of Cl secretion by
the bronchi of the old mice.
Older mice have reduced levels of Muc5b. To test whether
age affected the mucin content of mouse airways, we per-
formed mucin agarose Western blots on selected tissue repre-
sentative of three different lower airway compartments. Spe-
cifically, we studied tissue extracts from submucosal glands
(contained in the first four tracheal rings), trachea, and BAL
in young and old mice. As expected, tracheal sample weight
was higher in old mice compared with young mice and
correlated with the expected difference in body weight
between the two groups (data not shown). In contrast, there
was no significant difference in submucosal gland samples’
weight between young and old mice. Notably, we detected a
marked decrease in Muc5b levels in both tracheal and BAL
samples from old mice compared with young mice (Fig. 3,
A and B), whereas Muc5b levels were similar between the
two age groups in submucosal gland preparations (Fig. 3C).
Muc5ac was undetectable in all samples, regardless of
origin (not shown).
To further investigate the relationship between reduced lev-
els of Muc5b and MCC, we utilized the Muc5b knockout
mouse (Muc5b/). We have previously reported that the
Muc5b-deficient mice have severely reduced MCC that results
in the retention/accumulation of debris in the airways, leading
to infection and death (35). Interestingly, whereas the
Muc5b/ mouse has no detectable Muc5b, the heterozygotes
(Muc5b/) have 1/2 the level of Muc5b in BAL compared
with wild-type (WT) mice (Fig. 4A). To directly examine the
effect of reduced levels of Muc5b on MCC, we measured MCC
in the lower airways of Muc5b/, Muc5b/, and WT mice.
Fig. 1. A: effect of age on the rate of mucociliary clearance (MCC) from the
nasal cavity (anterior nasopharynx) in 3-mo-old and 2-yr-old male mice. Data
shown are means  SE, n  12 mice both groups. There was a statistically
significant difference between the 2 groups, ***P  0.001. B: effect of age on
the % beads cleared per 15 min from the lungs/trachea of 3-mo-old or 2-yr-old
male mice; n  10 both groups. There was a statistically significant difference
between the 2 groups, **P  0.01.
In agreement with our previous study, the Muc5b/ animals
had a severely reduced rate of MCC, clearing only 10% of
the fluorescent beads compared with the WT mouse (Fig. 4B).
Surprisingly, the Muc5b/ animals had a level of clearance
slightly less than half of that exhibited by the WT mice, thus
demonstrating that a reduced level of Muc5b is sufficient to
cause a significant inhibition of MCC (Fig. 4B). This suggests
that the reduction of Muc5b levels in the old mice may be
responsible for the decrease in MCC.
Old mice show signs of lung disease. Whereas histological
examination of lungs from the young animals typically dis-
played normal morphology, with only an occasional area of
lymphoid hyperplasia, lungs from the older animals consis-
tently showed a high incidence of bronchus-associated lym-
phoid tissue (BALT) (Fig. 5, A and B). A semiquantitative
analysis revealed a significant increase in the average number
of BALT foci in the lungs of the older animals (2.1 vs. 0.2;
P  0.001, Fig. 5C). Morphologically, these lymphoid aggre-
gates appeared loosely organized and lacking germinal centers,
suggesting inducible BALT (iBALT). As iBALT formation
has been associated with local infection or inflammation (13,
30), our results suggest that decreased MCC in older mice
might increase the incidence of endogenous or environmental
insults to the airway epithelium.
DISCUSSION
The aging of the population has been associated with in-
creased morbidity and mortality due to pulmonary diseases,
while morbidity and mortality from other diseases has re-
mained stable or declined (44). The increased incidence of lung
disease in the elderly is likely due to the complex interaction of
many age-associated changes (for reviews, see Refs. 14, 28).
These changes can include an altered immune response, an
increased risk of aspiration, a decrease in clearance mecha-
nisms (both cough and MCC), the presence of other systemic
diseases, and smoking or exposure to environmental pollutants.
The importance of each of these risk factors will vary between
individuals. For example, poor oral hygiene and increased
aspiration alone may not be pathogenic, but when accompanied
by a reduction in airway clearance mechanisms, may result in
an increase in pneumonias. Although there is evidence that
immune function declines with advanced age, even very old
individuals can often mount robust immune responses (28).
Thus, to reduce the incidence and severity of lung disease in
the elderly, it is necessary to understand the effect of aging on
both the innate and adaptive immune systems and to develop
treatment strategies appropriate for each.
One feature of the aging lung that is thought to contribute to
the susceptibility of the elderly to lung disease but has not been
Fig. 2. A: bioelectrics of tracheal epithelium for 2-mo-old
(solid bars) and 2-yr-old (gray bars) male mice. The “basal”
Isc is the steady-state short circuit prior to drug additions.
Then drugs were added in the order shown and as described
in the text. “
w/Amil” is change in Isc in response to
amiloride and the “Residual Isc” is the steady-state Isc
remaining following amiloride addition. Forsk, forskolin.
The basal Isc, residual Isc, and the response to UTP were
significantly different (*P  0.05) between the 2 groups.
The response to bumetanide is not shown as the responses
were 0 for both groups of mice. Data are from n  6 mice,
both groups. B: bioelectrics of bronchial epithelium for
2-mo-old (solid bars) and 2-yr-old (gray bars) male mice.
Drug additions were as indicated above. The residual Isc
(**P  0.01), the response to UTP (*P  0.05), and the
response to bumetanide (Bumet; **P  0.01) differed
significantly between groups; n  6 for the 3-mo-old mice
and n  5 for the 2-yr-old animals.
well studied is a decline in MCC (14, 28). MCC is known to be
one of the important defense mechanisms in maintaining pul-
monary health; however, there have been few investigations of
the effect of aging on MCC in the lungs of older individuals
(19, 29, 33, 41), with most reporting a decline in MCC with
increasing age. Other investigators have studied the effect of
aging on MCC in the nasal cavity with conflicting results. Ho
et al. (18) reported a significant negative correlation of age
with the rate of nasal MCC, whereas Kao et al. (20) did not find
an effect. Presently, it is not known whether nasal MCC is
representative of MCC in the lower airways.
The effect of aging on the individual components of MCC is
also not known. For example, in the study by Ho et al. (18), the
authors reported a significant decrease in nasal MCC, a de-
crease in CBF, and an increase in ciliary abnormalities in
individuals over the age of 40 (18). However, it is not clear
whether the ciliary defects were due to the process of aging or
whether they were the result of exposure to environmental
challenges, e.g., cigarette smoke (38, 40, 42). Indeed, aging of
humans is accompanied by years of exposure to air pollution,
environmental pathogens (viral, bacterial) and other insults to
the respiratory tract, making it difficult to separate the effect of
these insults from the normal response to aging. In contrast, in
the mouse model utilized in this study, both the old and young
animals were raised in a controlled environment with filtered
air, limiting the exposure to environmental pollutants and
pathogens. Thus, in our mouse model, the responses we ob-
serve will be more likely directly related to the normal aging
process. Moreover, we are not aware of any published studies
that attempted to determine whether the production of mucin is
increased or decreased in elderly individuals. Although it is
accepted that mucin hypersecretion is associated with diseases,
including chronic bronchitis and asthma (47, 48), it is less clear
what effect mucus hyposecretion may have on MCC. We
recently reported that deletion of the secreted mucin Muc5b in
a mouse model caused a severe decrease in MCC in the upper
and lower airways (35). Thus either too little or too much
mucin could be a cause of impaired MCC in the elderly.
Finally, the effect of aging on the bioelectric properties of the
airways is also unknown.
In this study, we sought to determine whether a mouse
model would exhibit a decline in MCC as a function of age,
Fig. 4. A: effect of Muc5b genotype on levels of Muc5b in BAL. Solid bars,
WT mice; gray bars, Muc5b/ mice; striped bars, Muc5b/ mice (n  6
each genotype; 5 wk old). The level of Muc5b was significantly reduced in the
Muc5b/ animals compared with WT (*P  0.05). B: effect of Muc5b
genotype on MCC. Solid bars, WT mice (n  3); gray bars, Muc5b/ mice
(n  10); striped bars, Muc5b/ mice (n  6). All animals were 6 mo old.
ANOVA indicated statistical difference (*P  0.05) from WT and each
genotype from the other (*P  0.05).
Fig. 3. Levels of Muc5b in young and old mice. A: level of Muc5b in tracheal
tissue from old mice was significantly less than the level in young mice; n 
10 mice/group. B: level of Muc5b in BAL fluid from old mice was also
significantly reduced, relative to the young mice; n  9 young mice; 10 old
mice. C: Muc5b levels in submucosal gland tissues were the same in young and
old mice; n  10 mice/group. Data are means  SE. **P 	 0.01, ***P 	
0.001.
and if so which of the major components of MCC (ion
transport, CBF, or mucin composition/quantity) may be in-
volved. We found that, in both the upper (nasal) and lower
airways, the rate of MCC was significantly decreased (50 and
60% respectively) in old mice compared with the younger
cohort. These data agree with earlier studies in both humans
and dogs (19, 33, 41, 50) and demonstrate that mice may be
useful to investigate the mechanisms responsible for the age-
dependent decrease in MCC.
We then examined three major components of MCC indi-
vidually to determine why MCC is decreased in old mice. As
CBF has been found to be positively correlated with the rate of
MCC (36), a reduction in CBF could be responsible for the
reduced rate of MCC we observed in the older mice. Other
studies have previously reported CBF to be reduced in older
animals (3). Therefore, we measured CBF in ex vivo prepara-
tions, i.e., isolated tracheal rings, from both young and old
mice. These studies revealed a small (	1 Hz) but significant
reduction in the CBF of older animals. CBF is known to
increase with increasing temperature, and therefore CBF in
vivo is likely greater then what we observed in vitro at 25°C.
However, because the increase in CBF with increasing tem-
perature is approximately linear (36, 39), the difference be-
tween old and young mice is expected to remain small. Our
result is also consistent with the study of Bailey et al. (3), who
reported a significantly reduced ( 3 Hz) CBF in 2-yr-old mice
compared with 2-mo-old mice. These investigators demon-
strated that the decrease in CBF is related to an increase in the
level of protein kinase C-ε. Based on studies of human ciliated
cells in culture, a reduction in CBF of 1 Hz can be estimated to
reduce MCC from 5 to 4.5 mm/min, a difference of only
10% (36). Although this likely contributes to the slowing of
MCC in the older mice, it does not appear to be sufficient by
itself to account for the 50% reduction of MCC observed.
The amount of the airway surface liquid (ASL) is also
critical to maintaining normal MCC. The volume of this layer
is regulated primarily by the rate of ion transport across the
airway epithelia. An increase in ion absorption, primarily Na,
from the lumen will result in a decrease in ASL volume as
water will passively follow the ions to maintain osmolality.
The decreased volume of ASL will dehydrate the mucus,
collapse the cilia (7) and result in a markedly decreased rate of
MCC, as demonstrated by the overexpression of -ENaC in a
mouse model (26). Similarly, an imbalance in ion transport,
e.g., reduced Cl secretion with persistent Na absorption,
will decrease water flow onto the epithelial surface and result
in a compromised ASL volume and reduced MCC, as observed
in cystic fibrosis (4, 5). Therefore, we measured airway bioel-
ectric properties in both tracheal and bronchial tissue from old
and young mice as an indicator of the ion transport capacity
and thus ASL regulation. Similar age-related changes were
observed in both tissues. The basal (unstimulated) Isc reflects
components of both electrogenic Na absorption and Cl
secretion (1, 34). In both the trachea and bronchi of the aged
mice, there was a significant reduction in Cl secretory com-
ponent of the basal Isc, reflected as a reduced postamiloride
residual Isc, with no significant age-related change in
amiloride-sensitive Na absorption in either tissue. In the
tracheas of the aged mice, because constitutive Cl secretion
was reduced, it is likely that there was a decrease in coupled
water secretion. From our data, it is not possible to determine
whether this defect in basal Cl secretion caused a decrease in
ASL volume and a decrease in MCC.
In addition, in both the aged tracheas and bronchi there was
a significant decrease (40%) in the response to UTP. We
have previously found that a significant fraction of the UTP
response in murine airway tissue is due to TMEM 16A-
mediated Cl secretion (34), thus it is likely that secretion
through this channel was reduced in both airway tissues as a
result of aging. Because nucleotide release rates can regulate
MCC, reduced UTP sensitive Cl secretion could contribute to
reduced ASL volume and reduced MCC.
In both humans and mice, MUC5B and MUC5AC are the
major secreted mucins comprising the primary component of
airway mucus and are mainly responsible for its rheological
properties (22, 45, 46). We have recently shown that, in mice,
Muc5b, but not Muc5ac, is necessary for normal airway MCC
(35). In our aged mice, we found a significant decrease in the
levels of Muc5b in BAL fluid, which sampled the lower
airways, and in tracheal extracts, compared with the Muc5b
levels detected in the same samples from young mice. The
Muc5b present in both the BAL and tracheal samples likely
reflects the baseline contribution from the club cells lining the
trachea and lower airways (51), as opposed to the Muc5b pool
Fig. 5. Old mice have a high incidence of BALT. A: hematoxylin and eosin
(H&E) section of left lobe from a young (3 mo old) mouse. B: H&E section of
left lobe from an old (2 yr) mouse showing BALT (arrows). C: semiquanti-
tative analysis of the incidence of BALT in the lungs of young and old mice
demonstrates a clear increase in the older animals. ***P  0.001; n  9 for
each age group.
found in the tracheal glands, which is mainly secreted follow-
ing neural stimulation. The constitutively secreted mucin from
the superficial epithelium is likely responsible for lining the
healthy airways and allowing normal MCC (51). In support of
this hypothesis, we have found that the levels of Muc5b
correlated with the rate of MCC in mouse airways, since the
Muc5b/ mice exhibited very low MCC and Muc5b
heterozygotes exhibited an 50% decrease in the levels of
BAL Muc5b (Fig. 4A) and MCC (Fig. 4B). Because we
observed a similar decrease in both Muc5b and MCC in the old
mice, it is likely that the lower level of Muc5b contributes to
the reduced MCC in the old animals.
Old mice also showed an increase in the incidence of BALT
(43). Similarly, we have observed an increased incidence of
BALT over time in a mouse model of primary ciliary dyski-
nesia in which MCC is also reduced (Ostrowski LE and
Livraghi-Butrico A, unpublished observation). Thus we further
hypothesize that the development of BALT in older mice may
arise in response to progressively poorer MCC, through stim-
ulation of mucosal innate immunity.
A major advantage of using the mouse to study the age-
related decline in MCC is that, because of its short life span,
these changes can be studied in a much shorter time frame
compared with humans or other animal models. In addition,
because mice are raised in a controlled environment, the
changes observed are less likely to be the result of exposure to
air pollutants, infectious agents, or other environmental factors.
However, there are differences between murine and human
airways that may impact on the usefulness of the mouse as a
model of human aging. For example, Muc5b is the predomi-
nant secreted mucin under baseline conditions in the mouse,
whereas human sputum contains both MUC5B and MUC5AC
(21, 22). In the mouse, only the most proximal trachea contains
submucosal glands, whereas in the human, submucosal glands
are abundant throughout the cartilaginous airways. Thus the
mouse trachea may be a good model for human small airways
that also lack glands. Additionally, in mouse airways, CFTR
does not play the major role in Cl secretion that it does in
human airways; instead Ca mediated Cl secretion predom-
inates (16). The impact of these differences between mouse
and human airways needs to be taken into account when
interpreting the data. In the mouse model, we observed a
decrease in MCC in the nasal cavity as well as the lower
airways of the old mice. This finding suggests that the nasal
cavity may be a good model for studying the effects of aging
on the lower airways. Furthermore, if these data are applicable
to the human, the human nasal cavity may be a good model for
studying the effect of aging on MCC, as nasal epithelia are
clearly much easier to study than the lower airways.
We could not locate any published studies regarding the
levels of MUC5B protein in human airways as a function of
aging. However, in humans, many muco-obstructive lung dis-
eases are characterized by an increase in mucin secretion,
including MUC5B [e.g., chronic bronchitis, cystic fibrosis (17,
22)]. With these diseases, it is likely that a marked increase in
the total concentration of mucus contributes to the reduced
MCC. Current and developing therapies for these diseases are
designed to clear mucus from the airways by improving mucus
transportability (DNase, hypertonic saline, mucolytics), or de-
creasing mucus secretion. Ironically, at least in the aged
mouse, therapies aimed at increasing the level of Muc5b
production may be beneficial in normalizing the age-related
compromise in MCC.
In conclusion, we have shown that the aged C5BL/6 mouse
exhibits significantly reduced rates of MCC in both the upper
and lower airways. This reduction is likely the result of a
combination of a decrease in CBF and a decrease in Cl and
mucin secretion. Given the magnitude of the changes, we
hypothesize that the age-dependent decline in MCC is likely
the result of the significantly decreased levels of Muc5b and/or
Cl secretion. Further studies will be needed to determine the
mechanism(s) for the decline in the Muc5b levels and Cl
secretion in the aging murine airways and whether therapies to
increase Muc5b and/or Cl secretion in the aged mouse will
return MCC levels to those of the younger animals.
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